5.65 USD
-0.02 (-0.35%)
5.62 USD
-0.03 (-0.53%)
ChartMill assigns a Buy % Consensus number of 85% to IMRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 17.17. This target is 203.89% above the current price.
IMRX was analyzed by 12 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about IMRX.
In the previous month the buy percentage consensus was at a similar level.
IMRX was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-10-31 | Leerink Partners | Initiate | Outperform |
| 2025-09-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-25 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-09-15 | Needham | Maintains | Buy -> Buy |
| 2025-08-26 | Needham | Reiterate | Buy -> Buy |
| 2025-08-14 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-18 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-06-18 | Needham | Reiterate | Buy -> Buy |
| 2025-06-05 | Needham | Reiterate | Buy -> Buy |
| 2025-05-07 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2025-05-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-10 | Needham | Reiterate | Buy -> Buy |
| 2025-03-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-21 | Needham | Reiterate | Buy -> Buy |
| 2025-02-06 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-07 | Needham | Reiterate | Buy -> Buy |
| 2024-11-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | Needham | Reiterate | Buy -> Buy |
| 2024-09-13 | Needham | Reiterate | Buy -> Buy |
| 2024-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-08-07 | Needham | Reiterate | Buy -> Buy |
| 2024-05-08 | Needham | Reiterate | Buy -> Buy |
| 2024-04-12 | Needham | Reiterate | Buy -> Buy |
| 2024-04-02 | Mizuho | Maintains | Buy -> Buy |
| 2024-03-15 | TD Cowen | Downgrade | Outperform -> Market Perform |
IMMUNEERING CORP - CLASS A / IMRX FAQ
What is the price target for IMRX stock?
12 analysts have analysed IMRX and the average price target is 17.17 USD. This implies a price increase of 203.89% is expected in the next year compared to the current price of 5.65.
How do analysts rate IMMUNEERING CORP - CLASS A (IMRX)?
The consensus rating for IMMUNEERING CORP - CLASS A (IMRX) is 85 / 100 . This indicates that analysts generally have a positive outlook on the stock.